U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Search Current & Recent Grants > Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke Print

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

HIV-associated Noncommunicable Diseases Research at LMIC Institutions

Project Information in NIH RePORTER

Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke

Principal Institution

Stellenbosch University

Principal Investigator(s) (PI)

Decloedt, Eric Hermann; Orrell, Catherine

Project Contact Information

Email: ericdecloedt@sun.ac.za

Year(s) Awarded

2023–2025

Country

South Africa

NIH Partners

OD/NIH

Project Description

The risk for stroke is two-fold higher in people with HIV (PWH) compared to people without HIV, despite antiretroviral therapy (ART) and viral suppression, and without many of the traditional stroke risk factors, suggesting ongoing HIV-associated inflammation as a potential driver of stroke risk. Adherence to ART sufficient to suppress viral loads to below the clinically-relevant threshold of 200 copies/mL may not be adequate to suppress viremia completely, with ongoing HIV-associated inflammation.

This project will conduct a comparative observational study in virally suppressed PWH presenting with stroke compared to PWH without stroke to obtain preliminary, exploratory data on the association between stroke and imperfect adherence to ART, viremia and the viral reservoir, and exploratory proteomic biomarkers.

Related World Regions / Countries

Related Global Health Research Topics